Metabolic Syndrome and Outcomes after Renal Intervention

Metabolic syndrome significantly increases the risk for cardiovascular disease and chronic kidney disease. The increased risk for cardiovascular diseases can partly be caused by a prothrombotic state that exists because of abdominal obesity. Multiple observational studies have consistently shown th...

Full description

Saved in:
Bibliographic Details
Main Authors: Daynene Vykoukal, Mark G. Davies
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.4061/2011/781035
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563624016609280
author Daynene Vykoukal
Mark G. Davies
author_facet Daynene Vykoukal
Mark G. Davies
author_sort Daynene Vykoukal
collection DOAJ
description Metabolic syndrome significantly increases the risk for cardiovascular disease and chronic kidney disease. The increased risk for cardiovascular diseases can partly be caused by a prothrombotic state that exists because of abdominal obesity. Multiple observational studies have consistently shown that increased body mass index as well as insulin resistance and increased fasting insulin levels is associated with chronic kidney disease, even after adjustment for related disorders. Metabolic syndrome appears to be a risk factor for chronic kidney disease, likely due to the combination of dysglycemia and high blood pressure. Metabolic syndrome is associated with markedly reduced renal clinical benefit and increased progression to hemodialysis following endovascular intervention for atherosclerotic renal artery stenosis. Metabolic syndrome is associated with inferior early outcomes for dialysis access procedures.
format Article
id doaj-art-2ad9bae441aa4d94815e5d6546685636
institution Kabale University
issn 2090-0597
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Cardiology Research and Practice
spelling doaj-art-2ad9bae441aa4d94815e5d65466856362025-02-03T01:12:55ZengWileyCardiology Research and Practice2090-05972011-01-01201110.4061/2011/781035781035Metabolic Syndrome and Outcomes after Renal InterventionDaynene Vykoukal0Mark G. Davies1Department of Cardiovascular Surgery, Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, 6550 Fannin, Smith Tower, Suite 1401, Houston, TX 77030, USADepartment of Cardiovascular Surgery, Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, 6550 Fannin, Smith Tower, Suite 1401, Houston, TX 77030, USAMetabolic syndrome significantly increases the risk for cardiovascular disease and chronic kidney disease. The increased risk for cardiovascular diseases can partly be caused by a prothrombotic state that exists because of abdominal obesity. Multiple observational studies have consistently shown that increased body mass index as well as insulin resistance and increased fasting insulin levels is associated with chronic kidney disease, even after adjustment for related disorders. Metabolic syndrome appears to be a risk factor for chronic kidney disease, likely due to the combination of dysglycemia and high blood pressure. Metabolic syndrome is associated with markedly reduced renal clinical benefit and increased progression to hemodialysis following endovascular intervention for atherosclerotic renal artery stenosis. Metabolic syndrome is associated with inferior early outcomes for dialysis access procedures.http://dx.doi.org/10.4061/2011/781035
spellingShingle Daynene Vykoukal
Mark G. Davies
Metabolic Syndrome and Outcomes after Renal Intervention
Cardiology Research and Practice
title Metabolic Syndrome and Outcomes after Renal Intervention
title_full Metabolic Syndrome and Outcomes after Renal Intervention
title_fullStr Metabolic Syndrome and Outcomes after Renal Intervention
title_full_unstemmed Metabolic Syndrome and Outcomes after Renal Intervention
title_short Metabolic Syndrome and Outcomes after Renal Intervention
title_sort metabolic syndrome and outcomes after renal intervention
url http://dx.doi.org/10.4061/2011/781035
work_keys_str_mv AT daynenevykoukal metabolicsyndromeandoutcomesafterrenalintervention
AT markgdavies metabolicsyndromeandoutcomesafterrenalintervention